447-61-0

应用筛选条件

关键词:'447-61-0'

显示 1-1 共 1 条结果关于 "447-61-0" 范围论文

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.

Kelly E Dooley et al.

The lancet. HIV, 7(6), e401-e409 (2020-04-03)

Short-course preventive therapy with 12 doses of once-weekly rifapentine (900 mg) plus isoniazid (900 mg) could greatly improve tuberculosis control, especially in areas with high co-endemicity with HIV. However, a small previous trial of such therapy with dolutegravir in healthy

1/1